ALLO

Conviction 51HealthcareScan · Thu, Jun 25, 2026

Bullish harami

ALLO$2.07+0.98%

ResistanceSupportVol 14Insider sell

Vol MA14 9.13M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Allogene Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.allogene.com ↗

Price2.07

Change+0.98%

Gap+0.00%

Rel volume2.18×

Avg volume8.85M

Avg $ vol17.69M

SMA 201.99

SMA 502.12

SMA 2001.78

Price vs 50-2.18%

Price vs 200+16.51%

MA stackmixed

50/200 cross—

Supertrenddown · 2.24

RSI (14)53

MACD hist0.03

MACD crossbull · 5d

Stoch %K / %D75 / 74

ADX (14)15

+DI / −DI26 / 17

RSI divergence—

MACD divergenceBullish

ATR %+6.73%

ADR %6.33%

52w high3.06

52w low1.03

From 52w high-32.35%

Above 52w low+100.97%

New 52w highNo

SqueezeOff

Bollinger width24.44%

%B0.66

Donchian pos60.38%

Donchian high2.28

Donchian low1.75

AVWAP (52w high)2.36

vs AVWAP high-12.22%

AVWAP (52w low)2.01

vs AVWAP low+3.20%

OBV trendFlat

Chaikin MF (20)-0.27

Today vs 20d2.18×

Avg vol (14d)9.13M

Avg vol (20d)8.85M

Avg $ vol (20d)17.69M

Market cap714.47M

RS 3m (vs SPY)-19.50%

RS 6m (vs SPY)+36.63%

RS line new highNo

Trend template5/8

Technical rank65.0

1 week+5.61%

1 month-2.36%

3 months-11.16%

6 months+40.82%

1 year+65.60%

YTD+53.33%

P/E-3.74

P/B2.56

P/S—

P/FCF-4.77

EPS-0.8700

Div yield—

ROE-68.45%

ROA-48.21%

Debt/Eq—

Current9.65

EV/EBITDA-3.47

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth25.90%

Price target8.59

Target upside314.98%

Analyst ratingBuy

Institutional51.16%

Ent. value684.16M

Revenue0

Net income-42.61M

Gross profit—

Free cash flow-149.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out345.15M

Employees152

ListedThu, Oct 11, 2018

Free float169.95M

Float %69.4%

Short interest44.48M

Days to cover6.8d

Short volume59.2%

Squeeze score93 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.18 vs −$0.19

Last surprise+5.3% beat

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank65.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALLO

All disclosures →

No recent disclosed trades by Congress in ALLO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALLO · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Yoshiyama Annie SVP, Finance · Common Stock · 2026-04-21	Sell	9.59K	$22K	2026-04-21	2026-04-23

SEC filings

EDGAR filings in ALLO · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.